Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)
Updated
Cooperative agreement from the National Institutes of Health, open to small businesses. Closes Jun 10, 2027, 208 days left.
| Opportunity number | RFA-MH-27-150 |
|---|---|
| Agency | National Institutes of Health |
| Funding type | Cooperative agreement |
| Field | Health |
| Expected number of awards | 3 |
| Total program funding | $12.0 million |
| Cost sharing or matching | Not required |
| Assistance listing | 93.24R, 93.DA1 |
| Posted | Nov 12, 2026 |
| Closes | Jun 10, 2027 (208 days left) |
| Add the deadline to | Google Calendar |
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state controlled institutions of higher education
- Native American tribal governments (federally recognized)
- Public housing authorities and Indian housing authorities
- Native American tribal organizations (other than federally recognized tribal governments)
- Nonprofits with 501(c)(3) status, other than institutions of higher education
- Nonprofits without 501(c)(3) status, other than institutions of higher education
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others (see the eligibility notes)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Description
This notice of funding opportunity (NOFO) encourages applications to establish a Rapid-Acting Psychotropic Interventional Drugs - Clinical Trials Network (RAPIDs-CTN). The overarching purpose is to generate actionable, real-world evidence to guide the safe and effective implementation of RAPIDs in routine clinical practice, answering urgent questions about how these treatments can be delivered sustainably outside tightly controlled experimental settings.
This NOFO utilizes a milestone-driven UM1 Cooperative Agreement mechanism structured into two operational stages: Stage 1 (Years 1–2) for network establishment and pilot studies, and Stage 2 (Years 3–5) focuses for full-scale execution of proposed pragmatic trials. This program is intended only for large-scale, coordinated network projects that could not be achieved using other, more standard grant mechanisms.
Full announcement and how to apply on Grants.gov
Health grants right now
There are 347 open federal grants in health that small businesses may apply for; 24 close within 30 days. The median award ceiling is $500,000. The agencies offering the most are National Institutes of Health, Centers for Disease Control and Prevention - ERA and Health Resources and Services Administration. Grants in this field stay open a median of 1035 days; this one is open for 210 days.
Other open grants in the same program
Under assistance listing 93.24R, 93.DA1, the federal program this grant is paid from.
More open grants from the National Institutes of Health
337 open grants from this agency accept small businesses, with $369.8 million in total program funding listed.